Sec Form 13G Filing - SJ Capital Co. Ltd. filing for DR FOODS INC (DRFS) - 2022-07-12

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

(Amendment No. ______)*

 

Dr. Foods, Inc.


(Name of Issuer)

 

Preferred Stock, $0.0001 par value per share

Common Stock, $0.0001 par value per share


(Title of Class of Securities)

 

The Issuer has no associated CUSIP number for its shares of Preferred Stock

Current CUSIP for Common Stock: 26140D107


(CUSIP Number)

 

May 31, 2021


(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☐ Rule 13d-1(b)

 

☒ Rule 13d-1(c)

 

☐ Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

  Page 1 of 5 Pages  

 

 

 

 

 


CUSIP: 26140D107 13G  Page  2  of  5  Pages

 

   
1.

Names of Reporting Persons.
 

SJ Capital Co., Ltd.

2. Check the Appropriate Box if a Member of a Group (See Instruction) (a) ☐
        (b) ☐
3.

SEC Use Only

 

4.

Citizenship or Place of Organization

Japan

 

Number of 5.

Sole Voting Power

307,692,308 shares of Common Stock

0 Shares of Preferred Stock

 

Shares
Beneficially
Owned by
6.

Shared Voting Power

 

0

Each
Reporting
Person With
7.

Sole Dispositive Power 

307,692,308 shares of Common Stock

0 Shares of Preferred Stock

    8.

Shared Dispositive Power

0

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person

307,692,308 shares of Common Stock

0 Shares of Preferred Stock

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

(See Instructions)

11.

Percent of Class Represented by Amount in Row 9

Common 11.73% (1)

Preferred 0.00% (1)

 

12.

Type of Reporting Person (See Instructions)

CO

 

  

(1) Based on 10,000 shares of Series Z Preferred Stock, and 2,622,968,890 shares of Common Stock of Dr. Foods, Inc., (the “Issuer”) outstanding as of July 7, 2022.

 


CUSIP: 26140D107 13G Page  3  of  5  Pages

 

ITEM1.

 

 

  (a) Name of Issuer
Dr. Foods, Inc.
  (b)

Address of Issuer’s Principal Executive Offices
3F K’s Minamiaoyama

6-6-20 Minamiaoyama, Minato-ku,Tokyo 107-0062, Japan

 

ITEM2.

 

  (a) Name of Person Filing
SJ Capital Co., Ltd.

 

  (b) Address of Principal Business Office or, if none, Residence
3-1-9 Kawara-machi, Chuo-ku, Osaka, Japan 541-0048

 

  (c) Citizenship or Place of Organization
Japan

 

  (d)

Title of Class of Securities

Common Stock $0.0001 par value per share

 

  (e) CUSIP Number
The current CUSIP for Common Stock of Dr. Foods, Inc. is 26140D107.

 

ITEM 3.    IF THIS STATEMENT IS FILED PURSUANT TO §§240.13D-1(B), OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A:

 


If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 

             
    (a)      Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
       
    (b)      Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
       
    (c)      Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
       
    (d)      Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
       
    (e)      An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E);
       
    (f)      An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
       
    (g)      A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
       
    (h)      A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
    (i)      A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
       
    (j)      Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 


CUSIP: 26140D107 13G Page  4  of  5  Pages

 

ITEM 4    OWNERSHIP.

The information relating to the beneficial ownership of Common Stock which the Reporting Person may be deemed to beneficially own set forth in Items 5-11 on the preceding pages of this Schedule 13G is incorporated herein by reference.

On or about May 31, 2022, Dr. Foods, Inc. sold 307,692,308 shares of restricted Common Stock to SJ Capital Co., Ltd., a Japanese Company, at a price of $0.0025 USD per share of Common Stock.

 

The aforementioned sale of shares was conducted pursuant to Regulation S of the Securities Act of 1933, as amended ("Regulation S"). The sale of shares was made only to non-U.S. persons/entities (as defined under Rule 902 section (k)(2)(i) of Regulation S), pursuant to offshore transactions, and no directed selling efforts were made in the United States by the issuer, a distributor, any of their respective affiliates, or any person acting on behalf of any of the foregoing. 

The aggregate amount of Stock held by SJ Capital Co., Ltd., a Japan Company, as of July 7, 2022, is 307,692,308 shares of Common Stock, which is approximately 11.73% of the class of Common Stock, and 2.43% voting control of Dr. Foods, Inc.

Takeshi Sugisawa, the Chief Executive Officer of SJ Capital Co., Ltd., authorized the aforementioned purchase of shares from Dr. Foods, Inc.

ITEM 5.    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

 

NOT APPLICABLE

 

ITEM 6.    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

 

NOT APPLICABLE

 

ITEM 7.    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON.

 

NOT APPLICABLE

 

ITEM 8.    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

 

NOT APPLICABLE

 

ITEM 9.    NOTICE OF DISSOLUTION OF GROUP.

 

NOT APPLICABLE

 

ITEM 10.   CERTIFICATIONS.

 

NOT APPLICABLE 


CUSIP: 26140D107 13G Page  5  of  5  Pages

 

SIGNATURE

 

After reasonable inquiry and to the best of its knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  July 7, 2022  
  (Date)  
     
 

/s/ Takeshi Sugisawa

Chief Executive Officer

 
  (Signature)